OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
412856

Microbio Co Ltd

Food ProcessingVerified

Microbio Co., Ltd. has a liquidity ratio of 4.3, indicating a strong ability to meet short-term obligations, but its free cash flow is negative at -748.27 million TWD, suggesting cash outflows from operations exceed capital expenditures. The company's debt-to-equity ratio is 0.07, which is relatively low, but its net income is negative at -757.75 million TWD, indicating a financial challenge in generating profits. The company's return on equity is -8.5%, and its return on assets is -6.14%, both significantly below the industry norms for Food Processing, which typically show positive returns. This indicates that the company is underperforming in terms of profitability and asset utilization. Microbio Co., Ltd. operates primarily within the domestic market, with no disclosed international revenue segments. The company's revenue concentration is entirely within its home market, which may expose it to regional economic fluctuations and regulatory changes. The company's revenue for the latest period is 1.89 billion TWD, but it is not provided with a growth trajectory or outlook for the current or next fiscal year. The negative net income and operating income suggest a need for strategic adjustments to improve financial performance. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. However, the key flag of negative net cash after subtracting total debt highlights a potential liquidity constraint. The company's dilution potential is low, but the negative free cash flow may necessitate external financing, which could affect equity value. There are no recent events or filings mentioned in the provided data that would indicate significant changes in the company's operations or financial status. The company's financial snapshot does not include recent transcripts or filings that could provide additional context.

30-day price · 4128-0.65 (-3.9%)
Low$14.20High$18.20Close$16.05As of21 May, 00:00 UTC
Profile
CompanyMicrobio Co Ltd
Ticker4128.TWO
SectorConsumer Non-Cyclicals
BusinessFood & Beverages
Industry groupFood & Beverages
IndustryFood Processing
AI analysis

Business. Microbio Co., Ltd. is a Taiwan-based company engaged in the research, development, manufacture, distribution, and wholesale of healthcare food products and pharmaceuticals, including fermentation products, herbal products, organic foods, and new medicines.

Classification. Microbio Co., Ltd. is classified under the Consumer Non-Cyclicals economic sector, Food & Beverages business sector, and Food Processing industry with a confidence level of 0.92.

Microbio Co., Ltd. has a liquidity ratio of 4.3, indicating a strong ability to meet short-term obligations, but its free cash flow is negative at -748.27 million TWD, suggesting cash outflows from operations exceed capital expenditures. The company's debt-to-equity ratio is 0.07, which is relatively low, but its net income is negative at -757.75 million TWD, indicating a financial challenge in generating profits. The company's return on equity is -8.5%, and its return on assets is -6.14%, both significantly below the industry norms for Food Processing, which typically show positive returns. This indicates that the company is underperforming in terms of profitability and asset utilization. Microbio Co., Ltd. operates primarily within the domestic market, with no disclosed international revenue segments. The company's revenue concentration is entirely within its home market, which may expose it to regional economic fluctuations and regulatory changes. The company's revenue for the latest period is 1.89 billion TWD, but it is not provided with a growth trajectory or outlook for the current or next fiscal year. The negative net income and operating income suggest a need for strategic adjustments to improve financial performance. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. However, the key flag of negative net cash after subtracting total debt highlights a potential liquidity constraint. The company's dilution potential is low, but the negative free cash flow may necessitate external financing, which could affect equity value. There are no recent events or filings mentioned in the provided data that would indicate significant changes in the company's operations or financial status. The company's financial snapshot does not include recent transcripts or filings that could provide additional context.
Key takeaways
  • Microbio Co., Ltd. has a strong liquidity position with a current ratio of 4.3 but faces a negative free cash flow of -748.27 million TWD.
  • The company's return on equity and return on assets are both negative, indicating poor profitability and asset utilization.
  • The company's operations are concentrated in the domestic market, which may increase its exposure to regional economic and regulatory risks.
  • The company's financial performance is challenged by a negative net income and operating income, suggesting a need for strategic adjustments.
  • The company's liquidity risk is medium, and its dilution risk is low, but the negative net cash after subtracting total debt is a key financial flag.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$1.89B
Gross profit$753.5M
Operating income-$415.2M
Net income-$757.7M
R&D
SG&A
D&A
SBC
Operating cash flow$85.3M
CapEx-$69.2M
Free cash flow-$748.3M
Total assets$12.33B
Total liabilities$3.42B
Total equity$8.91B
Cash & equivalents$70.0M
Long-term debt$667.2M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$8.91B
Net cash-$597.2M
Current ratio4.3
Debt/Equity0.1
ROA-6.1%
ROE-8.5%
Cash conversion-11.0%
CapEx/Revenue-3.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food Processing · cohort 6 companies
Metric4128Activity
Op margin-21.9%3.3% medp25 2.5% · p75 4.5%bottom quartile
Net margin-40.0%3.0% medp25 1.5% · p75 6.7%bottom quartile
Gross margin39.8%24.0% medp25 20.2% · p75 35.3%top quartile
R&D / revenue0.8% medp25 0.5% · p75 2.3%
CapEx / revenue-3.6%5.2% medp25 4.8% · p75 5.7%bottom quartile
Debt / equity7.0%33.5% medp25 29.1% · p75 81.5%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 14:36 UTC#0bac5218
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 14:38 UTCJob: 70e22fec